0000908662-15-000260.txt : 20150629 0000908662-15-000260.hdr.sgml : 20150629 20150629142258 ACCESSION NUMBER: 0000908662-15-000260 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150629 DATE AS OF CHANGE: 20150629 EFFECTIVENESS DATE: 20150629 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neurovance, Inc. CENTRAL INDEX KEY: 0001544176 IRS NUMBER: 454090332 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-185561 FILM NUMBER: 15957650 BUSINESS ADDRESS: STREET 1: 43 THORNDIKE STREET STREET 2: SUITE S1-3 CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-758-0300 MAIL ADDRESS: STREET 1: 43 THORNDIKE STREET STREET 2: SUITE S1-3 CITY: CAMBRIDGE STATE: MA ZIP: 02141 D/A 1 primary_doc.xml X0707 D/A LIVE 0001544176 Neurovance, Inc. 43 THORNDIKE STREET SUITE S1-3 CAMBRIDGE MA MASSACHUSETTS 02141 617-758-0300 DELAWARE None None Corporation true 2011 Anthony A. McKinney 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Director President and CEO Franklin P. Bymaster 8545 N. Country Road 650 East Brownsburg IN INDIANA 46112 Executive Officer Chief Scientific Officer Campbell Murray Novartis BioVentures Ltd. Five Cambridge Center, Suite 603 Cambridge MA MASSACHUSETTS 02142 Director Daniel Omstead Tekla Healthcare/Tekla Life Sciences Inv 2 Liberty Square, 9th Floor Boston MA MASSACHUSETTS 02109 Director Brigitte Smith GBS Venture Partners Limited Level 5, 71 Collins Street Melbourne VIC C3 AUSTRALIA 3000 Director Paul Weiss Venture Investors Early Stage Fund IV 505 South Rosa Road, Suite 201 Madison WI WISCONSIN 53719 Director Timothy J. Barberich 48 Elm Street Concord MA MASSACHUSETTS 01742 Director William T. Pappafotopoulos 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Chief Operating Officer Brigitte Robertson 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Chief Medical Officer Albert L. Sokol 111 Huntington Avenue Boston MA MASSACHUSETTS 02199 Executive Officer Secretary Biotechnology No Revenues 06b true 0001140361-12-043764 2012-10-11 true true false 16345 26499997 26499997 0 Closed in 7 tranches. 1: $2,999,999 closed 10/11/12; 2: $2,999,999 closed 4/23/13; 3: $1,500,000 closed 10/10/13; 4: $3,000,003 closed 3/14/14; 5: $4,000,000 closed 8/29/14; 6: $5,500,000 closed 3/18/15; 7: $6,499,995 closed 6/26/15. false 7 0 0 0 true false Neurovance, Inc. /s/ Albert L. Sokol Albert L. Sokol Secretary 2015-06-29